DPIIT recognised startup Government of India
Startup India
Suntas Pharmaceuticals Private Limited
Suntas Pharmaceuticals Private Limited - healthcare in Bhopal, Madhya Pradesh, India. Directors, charges & compliance details.
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
Last AGM
30 Sep 2025
Annual general meeting
Company status
Active
MCA master data
Registrar
Gwalior
ROC office
About Suntas Pharmaceuticals Private Limited
Data last updated:
Suntas Pharmaceuticals Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India, recognised as a startup by DPIIT. It operates in the healthcare services segment of the healthcare sector. It was incorporated on 08 March 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U85100MP2021PTC055261.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Tarun Suryawanshi and Kaushal Suryawanshekumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No T – 1 Plot No. 19 Nova Arcade Medicine Street Balvihar Hamidia Road, Bhopal, Madhya Pradesh, India – 462001.
Company details
CIN U85100MP2021PTC055261
Registration Number 055261
Incorporation Date 08 March 2021
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
Recognitions & Rankings of Suntas Pharmaceuticals
Contact details
Suntas Pharmaceuticals Private Limited's registered office is in Bhopal, Madhya Pradesh.
- Registered AddressShop No T – 1 Plot No. 19 Nova Arcade Medicine Street Balvihar Hamidia Road, Bhopal, Madhya Pradesh, India – 462001
- IndustryHealthcare, Human Health Activities
Comprehensive company report
Suntas Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Suntas Pharmaceuticals Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Suntas Pharmaceuticals Private Limited, buy the company report.
Board of directors of Suntas Pharmaceuticals Private Limited
Suntas Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tarun Suryawanshi | Director | 08 Mar 2021 | 5 Years 7 Months | Current |
| Kaushal Suryawanshekumar | Director | 08 Mar 2021 | 5 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Suntas Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Suntas Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Suntas Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Suntas Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Kaushal Suryawanshekumar was appointed as Director on 08 Mar 2021.
AGM
Suntas Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Suntas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Appointed
Kaushal Suryawanshekumar was appointed as Director.
Appointed
Tarun Suryawanshi was appointed as Director.
Incorporation
08 Mar 2021
Suntas Pharmaceuticals Private Limited was registered on 08 Mar 2021 with Roc Gwalior & aged 5 years 7 months as per MCA records.
Frequently asked questions
Suntas Pharmaceuticals is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in human health activities, within the healthcare industry. It was incorporated on 08 March 2021 (5+ years old) and is registered under CIN U85100MP2021PTC055261.
Suntas Pharmaceuticals has 2 current directors:
- Tarun Suryawanshi - Director
- Kaushal Suryawanshekumar - Director
The latest financial statements of Suntas Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Suntas Pharmaceuticals is U85100MP2021PTC055261. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Suntas Pharmaceuticals was incorporated on 08 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Gwalior.
Kaushal Suryawanshekumar was appointed as Director on 08 Mar 2021. Tarun Suryawanshi was appointed as Director on 08 Mar 2021.
Yes, Suntas Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Suntas Pharmaceuticals is at Shop No T – 1 Plot No. 19 Nova Arcade Medicine Street Balvihar Hamidia Road, Bhopal, Madhya Pradesh, India – 462001.
Suntas Pharmaceuticals operates in the healthcare industry, in the human health activities segment.
Suntas Pharmaceuticals can be reached at its registered office: Shop No T – 1 Plot No. 19 Nova Arcade Medicine Street Balvihar Hamidia Road, Bhopal, Madhya Pradesh, India – 462001.